Anish Suri, Chief Scientific Officer at Cue Biopharma, Inc. (CUE), bought 2,000 shares at $4.37 ($9K) on 2018-12-21, disclosed to the SEC on 2018-12-26.
Open-market purchase of $9k CUE by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CUE | SELL | 2021-11-15 | $301K | — | Filing → |
| CUE | SELL | 2021-09-27 | $305K | — | Filing → |
| CUE | SELL | 2020-08-07 | $16K | — | Filing → |